Turbo Cancer Treatment Race Is On: Johnson & Johnson Just Completed $2 Billion Cancer Drug Buy of Ambrx
Merck, Novartis, Sanofi, Eli Lilly, AbbVie, Pfizer, BMS – they all want in!
Articles reviewed:
11, 2024 – Pfizer bets on cancer drugs to recover from rapid decline of covid business
11, 2024 – Merck Completes Acquisition of Harpoon Therapeutics
7, 2024 – Johnson & Johnson Completes Acquisition of Ambrx ($2.0 billion)…
Read More...
Read More...